Tengjun Biotechnology (TJBH) 10-Q 15 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	8-May-15
Document and Entity Information
Entity Registrant Name	China Herb Group Holdings Corp
Entity Central Index Key	1499785
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		36,443,119

Balance_Sheets

Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and cash equivalents	$3,090	$2,122
Prepaid expenses	400	100
TOTAL CURRENT ASSETS	3,490	2,222
TOTAL ASSETS	3,490	2,222
CURRENT LIABILITIES:
Accounts payable	10,525	3,846
Related party loans	106,923	89,777
TOTAL CURRENT LIABILITIES	117,448	93,623
STOCKHOLDERS' DEFICIT:
Preferred stock, $.001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $.001 par value, 70,000,000 shares authorized, 36,443,119 shares issued and outstanding at March 31, 2015 and December 31, 2014	36,443	36,443
Additional paid-in capital	106,322	104,753
Accumulated deficit	-256,723	-232,597
TOTAL STOCKHOLDERS' DEFICIT	-113,958	-91,401
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$3,490	$2,222

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Balance Sheets [Abstract]
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	36,443,119	36,443,119
Common stock, shares outstanding	36,443,119	36,443,119

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Revenues
Operating Expenses:
General and administrative	432	18,000
Legal fees	20,025	1,000
Accounting fees	1,500	19,500
Transfer agent fees	600	1,100
Consulting fees		12,000
Travel		4,500
Website		1,000
Total Operating Expenses	22,557	57,100
Loss from Operations	-22,557	-57,100
Other Expenses:
Interest expense - related party	-1,569	-1,087
Total Other Expense	-1,569	-1,087
Net Loss	($24,126)	($58,187)
Net loss per common share, basic and diluted	$0	$0
Weighted average number of common shares outstanding:
Basic and diluted	36,443,119	36,443,119

Statements_of_Cash_Flow_Unaudi

Statements of Cash Flow (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	($24,126)	($58,187)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loans	1,569	1,087
Changes in operating assets and liabilities:
(Increase) in prepaid expenses	-300
Increase in accounts payable	6,679
NET CASH USED IN OPERATING ACTIVITIES	-16,178	-57,100
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from loan from officer	17,146	57,100
NET CASH PROVIDED BY FINANCING ACTIVITIES	17,146	57,100
NET INCREASE IN CASH	968
Cash, beginning of year	2,122	32,143
Cash, end of period	3,090	32,143
SUPPLEMENTAL DISCLOSURES:
Interest Paid
Income taxes paid

Organization

Organization	3 Months Ended
	Mar. 31, 2015
Organization [Abstract]
Organization	NOTE 1 - Organization
	China Herb Group Holdings Corporation (the “Company”) was incorporated under the name “Island Radio, Inc.” under the laws of the State of Nevada on June 28, 2010.
	On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the “Sellers”), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the “Purchasers”), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the “Change in Control”). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company.
	The Company’s original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People’s Republic of China, the Company’s management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company’s plan of operations is to evaluate various industries, and geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company’s has extremely limited liquidity. Through March 31, 2015, the Company has no revenues or operations.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - Summary of Significant Accounting Policies
	Unaudited Interim Financial Information
	The accompanying balance sheet as of March 31, 2015, statements of operations for the three months ended March 31, 2015 and 2014, and the statements of cash flows for the three months ended March 31, 2015 and 2014 are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America (“U.S. GAAP”). In the opinion of the Company’s management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company’s statement of financial position at March 31, 2015 and its results of operations and its cash flows for the period ended March 31, 2015. The results for the period ended March 31, 2015 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2015.
	Basis of Presentation
	The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position and operating results as of and for the three months ended March 31, 2015 and 2014.
	Use of Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2015 and December 31, 2014, the Company had no cash equivalents.
	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	As of March 31, 2015 and December 31, 2014 we believe that the recorded values of all of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	Description	Level 1	Level 2	Level 3	Total Realized Loss
	31-Mar-15	-	-	-	-
	31-Dec-14	-	-	-	-
	Totals	-	-	-	-
	Net Loss per Share Calculation
	Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three-month periods ended March 31, 2015 and 2014, the Company had no dilutive financial instruments issued or outstanding.
	Income Taxes
	The Company accounts for income taxes pursuant to FASB ASC 740, Income Taxes. Under FASB ASC 740-10-25, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. China Herb Group Holdings Corporation establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about its ability to realize the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
	Prepaid Expenses
	Prepaid expenses relates to cash paid in advance for rent. These amounts are recognized as expense over the service period.
	Fiscal Year
	The Company elected December 31st for its fiscal year end.

Going_Concern

Going Concern	3 Months Ended
	Mar. 31, 2015
Going Concern [Abstract]
Going Concern	NOTE 3 - Going Concern
	The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions.
	As of March 31, 2015, the Company had $3,090 in cash. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company.
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United State of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of March 31, 2015, the Company had an accumulated deficit of $(256,723). These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 - Related Party Transactions
	Shareholder loans
	During the year ended December 31, 2013, Chin Yung Kong, the then director and a shareholder of the Company, advanced $20,000 to the Company for working capital purposes. These working capital advances of $20,000 are payable on demand and, at March 31, 2015 and December 31, 2014, reflected as shareholder loans on the accompanying balance sheets.
	During the three months ended March 31, 2015 and 2014, Qiuping Lu, President, Chief Executive Officer, director and a shareholder of the Company, advanced $17,146 and $57,100 to the Company for working capital purposes, respectively. These working capital advances of $86,923 are payable on demand and are reflected as shareholder loans on the accompanying balance sheet.
	During the three months ended March 31, 2015 and 2014, the Company imputed interest of $1,569 and $1,087 and recorded interest expense and an increase in paid-in capital, respectively.

Common_Stock

Common Stock	3 Months Ended
	Mar. 31, 2015
Common Stock [Abstract]
Common Stock	NOTE 5 - Common Stock
	The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share.
	As of March 31, 2015 and December 31, 2014, the Company had 36,443,119 shares of common stock issued and outstanding.

Preferred_Stock

Preferred Stock	3 Months Ended
	Mar. 31, 2015
Preferred Stock [Abstract]
Preferred Stock	NOTE 6 - Preferred Stock
	The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share.
	As of March 31, 2015 and December 31, 2014, the Company had no shares of preferred stock issued and outstanding.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	NOTE 7 - Recent Accounting Pronouncements
	On August 2014, FASB issued Accounting Standard Update No. 2014-15, Presentation of Financial Statements – Going Concerns (Subtopic 205-40): Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.
	In June 2014, FASB issued Accounting Standards Update (“ASU”) 2014-10, “Development Stage Entities”. The amendments in this update remove the definition of a development stage entity from the Master Glossary of the ASC thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP.  In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments in this update are applied retrospectively. The adoption of ASU 2014-10 removed the development stage entity financial reporting requirements from the Company.
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and do not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial statements.

Commitment

Commitment	3 Months Ended
	Mar. 31, 2015
Commitment [Abstract]
Commitment	NOTE 8 - Commitment
	On April 4, 2014 the Company entered into a memorandum of understanding (the “MOU”) with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence were to provide certain services to the Company and the Company was to have issued 10% of the issued and outstanding shares of the Company’s common stock to each of Dr. Pandelisev and Ms. Lawrence upon the completion of a reverse merger with a previously identified operating company, which reverse merger did not and will not take place. Pursuant to ASC 505-50, the Company did not recognize any expense during the period since the issuance of these shares is contingent upon the completion of a specific merger. Accordingly, no performance commitment has been reached nor has performance been completed.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	NOTE 9 - Subsequent Events
	The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined there are no additional events required to be disclosed.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Unaudited Interim Financial Information	Unaudited Interim Financial Information
	The accompanying balance sheet as of March 31, 2015, statements of operations for the three months ended March 31, 2015 and 2014, and the statements of cash flows for the three months ended March 31, 2015 and 2014 are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America (“U.S. GAAP”). In the opinion of the Company’s management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company’s statement of financial position at March 31, 2015 and its results of operations and its cash flows for the period ended March 31, 2015. The results for the period ended March 31, 2015 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2015.
Basis of Presentation	Basis of Presentation
	The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position and operating results as of and for the three months ended March 31, 2015 and 2014.
Use of Estimates	Use of Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2015 and December 31, 2014, the Company had no cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	As of March 31, 2015 and December 31, 2014 we believe that the recorded values of all of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	Description	Level 1	Level 2	Level 3	Total Realized Loss
	31-Mar-15	-	-	-	-
	31-Dec-14	-	-	-	-
	Totals	-	-	-	-
Net Loss per Share Calculation	Net Loss per Share Calculation
	Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three-month periods ended March 31, 2015 and 2014, the Company had no dilutive financial instruments issued or outstanding.
Income Taxes	Income Taxes
	The Company accounts for income taxes pursuant to FASB ASC 740, Income Taxes. Under FASB ASC 740-10-25, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. China Herb Group Holdings Corporation establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about its ability to realize the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
Prepaid Expenses	Prepaid Expenses
	Prepaid expenses relates to cash paid in advance for rent. These amounts are recognized as expense over the service period.
Fiscal Year	Fiscal Year
	The Company elected December 31st for its fiscal year end.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Summary of financial instruments of fair value current	Description	Level 1	Level 2	Level 3	Total Realized Loss
	31-Mar-15	-	-	-	-
	31-Dec-14	-	-	-	-
	Totals	-	-	-	-

Organization_Details

Organization (Details) (USD $)	1 Months Ended
	Jun. 27, 2012
Organization [Abstract]
Issuance of company's common stock, Shares	4,000,000
Total purchase price	$159,970
Percentage of Company's common stock issued and outstanding	93.00%

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss

Going_Concern_Details

Going Concern (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Going Concern [Abstract]
Cash and cash equivalents	$3,090	$2,122	$32,143	$32,143
Accumulated deficit	$256,723	$232,597

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Related Party Transaction [Line Items]
Due to related parties	$106,923		$89,777
Imputed interest	1,569	1,087
President, CEO, director and a shareholder [Member]
Related Party Transaction [Line Items]
Due to related parties	$17,146	$57,100		$20,000

Common_Stock_Details

Common Stock (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Common Stock [Abstract]
Common stock, shares authorized	70,000,000	70,000,000
Common stock, par value	$0.00	$0.00
Common stock, shares issued	36,443,119	36,443,119
Common stock, shares outstanding	36,443,119	36,443,119

Preferred_Stock_Details

Preferred Stock (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred Stock [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Recent_Accounting_Pronouncemen1

Recent Accounting Pronouncements (Details)	3 Months Ended
	Mar. 31, 2015
Recent Accounting Pronouncements [Abstract]
Description of accounting pronouncements	(1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).
Description of development stage entities	(1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage.

Commitment_Details

Commitment (Details)	3 Months Ended
	Mar. 31, 2015
Commitment [Abstract]
Commitment description	The Company entered into a memorandum of understanding (the "MOU") with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence were to provide certain services to the Company and the Company was to have issued 10% of the issued and outstanding shares of the Company's common stock to each of Dr. Pandelisev and Ms. Lawrence upon the completion of a reverse merger with a previously identified operating company, which reverse merger did not and will not take place.